Skip to content

Omnicell

US · OMCL #2961 by market cap Listed 1970
32.51 -0.67 -2.02%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 32.98 -0.60%
After-hours 32.51 0.00%
47.0032.2332.512026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on OMCL?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -6.8% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 8.3% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall C
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 33.9x Better than 18%
Forward P/E 36.5x Better than 12%
Price / Sales 1.3x Better than 71%
P/E vs own 5-yr range 35th pctl Better than 71%
Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) -2.9% Better than 15%
Net income CAGR (3Y) -28.6% Better than 11%
Free cash flow CAGR (3Y) 59.7% Better than 87%
Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 42.5% Better than 52%
Operating margin 0.4% Better than 22%
Net margin 0.2% Better than 26%
Return on equity 0.2% Better than 28%
Return on invested capital 0.1% Better than 29%
Momentum C

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -8.6% Better than 54%
6-month return -26.8% Better than 21%
12-month return (ex latest month) 4.9% Better than 40%
Distance below 52-week high 40.9% Better than 27%
Financial Health A

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.4x Better than 38%
Debt to assets 10.3% Better than 69%
Interest coverage 288.1x Better than 96%
Free cash flow / net income 3,380.5% Better than 99%
Analyst View A-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 83.3% Better than 63%
Upside to average target 73.3% Better than 77%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -7.19%
1M -10.91%
3M -8.42%
6M -27.30%
YTD -28.23%
1Y -5.27%
3Y -1.48%
5Y -82.26%

Key statistics

Price & volume

Prev close
33.18
Open
32.93
Day range
32.27 - 33.39
Avg price
32.61
Volume
564.53K
Turnover
18.41M
Amplitude
3.38%
52-week range
31.75 - 55.00

Valuation

P/E
812.75
P/E (TTM)
33.86
P/B
1.14
EPS
0.04
Net profit
1.84M
Net assets
1.32B

Share structure

Market cap
1.50B
Float cap
1.45B
Shares out
46.00M
Float shares
44.70M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 3% of range
31.75 55.00

40.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-3.35M net over the window

Short interest

Shares short
3.77M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Omnicell (OMCL)?

Omnicell last traded at 32.51. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Omnicell's market cap?

About 1.50B.

What is the P/E ratio of Omnicell?

The trailing twelve-month P/E is 33.86, below its own 5-year average of 69.74 — in the middle of its historical range (35.25% percentile). See the Valuation tab for the full history.

Does Omnicell pay a dividend?

Omnicell does not currently pay a regular dividend.

Is Omnicell a buy according to analysts?

The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 56.33, which implies 73.3% upside from the current price. This is not investment advice.

What is Omnicell's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Omnicell a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 20:02:40 · For reference only, not investment advice and not tailored to your situation.

Omnicell discussion 0 comments

Add a comment